Dapagliflozin and Ticagrelor Have Additive Effects on the Attenuation of the Activation of the NLRP3 Inflammasome and the Progression of Diabetic Cardiomyopathy: an AMPK–mTOR Interplay
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dapagliflozin and Ticagrelor Have Additive Effects on the Attenuation of the Activation of the NLRP3 Inflammasome and the Progression of Diabetic Cardiomyopathy: an AMPK–mTOR Interplay
Authors
Keywords
-
Journal
CARDIOVASCULAR DRUGS AND THERAPY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-04-25
DOI
10.1007/s10557-020-06978-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Empagliflozin Blunts Worsening Cardiac Dysfunction Associated With Reduced NLRP3 (Nucleotide-Binding Domain-Like Receptor Protein 3) Inflammasome Activation in Heart Failure
- (2020) Nikole J. Byrne et al. Circulation-Heart Failure
- Dapagliflozin and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Prior Myocardial Infarction: A Sub-analysis From DECLARE TIMI-58 Trial
- (2019) Remo H. M. Furtado et al. CIRCULATION
- Erythrocyte Adenosine A2B Receptor-Mediated AMPK Activation: A Missing Component Counteracting CKD by Promoting Oxygen Delivery
- (2019) Zhangzhe Peng et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Effects of ticagrelor, empagliflozin and tamoxifen against experimentally-induced vascular reactivity defects in rats in vivo and in vitro
- (2019) Yasmin Moustafa Ahmed et al. Pharmacological Reports
- 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
- (2019) Francesco Cosentino et al. EUROPEAN HEART JOURNAL
- Enhanced mTOR complex 1 signaling attenuates diabetic cardiac injury in OVE26 mice
- (2019) Xianmin Xu et al. FASEB JOURNAL
- Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial
- (2019) Deepak L Bhatt et al. LANCET
- Ticagrelor in Patients with Stable Coronary Disease and Diabetes
- (2019) P. Gabriel Steg et al. NEW ENGLAND JOURNAL OF MEDICINE
- A 2A Receptor Activation Attenuates Hypertensive Cardiac Remodeling via Promoting Brown Adipose Tissue-Derived FGF21
- (2018) Cheng-Chao Ruan et al. Cell Metabolism
- New Insights Into the Role of mTOR Signaling in the Cardiovascular System
- (2018) Sebastiano Sciarretta et al. CIRCULATION RESEARCH
- Inflammasome, pyroptosis, and cytokines in myocardial ischemia-reperfusion injury
- (2018) Stefano Toldo et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- P2Y12 antagonists and cardiac repair post-myocardial infarction: global and regional heart function analysis and molecular assessments in pigs
- (2018) Gemma Vilahur et al. CARDIOVASCULAR RESEARCH
- FOXO3a-dependent up-regulation of Mxi1-0 promotes hypoxia-induced apoptosis in endothelial cells
- (2018) Zhenzhen Hu et al. CELLULAR SIGNALLING
- Ageratina adenophora induces mice hepatotoxicity via ROS-NLRP3-mediated pyroptosis
- (2018) Wei Sun et al. Scientific Reports
- Dapagliflozin Attenuates Na+/H+ Exchanger-1 in Cardiofibroblasts via AMPK Activation
- (2018) Yumei Ye et al. CARDIOVASCULAR DRUGS AND THERAPY
- Structure and Physiological Regulation of AMPK
- (2018) Yan Yan et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
- (2018) Stephen D. Wiviott et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ticagrelor and Rosuvastatin Have Additive Cardioprotective Effects via Adenosine
- (2016) Yochai Birnbaum et al. CARDIOVASCULAR DRUGS AND THERAPY
- Targeting the energy guardian AMPK: another avenue for treating cardiomyopathy?
- (2016) Tian Li et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- β-Hydroxybutyrate suppresses inflammasome formation by ameliorating endoplasmic reticulum stress via AMPK activation
- (2016) Ha Ram Bae et al. Oncotarget
- The beneficial effects of AMP kinase activation against oxidative stress are associated with prevention of PPARα-cyclophilin D interaction in cardiomyocytes
- (2015) Giselle Barreto-Torres et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Ticagrelor Protects the Heart Against Reperfusion Injury and Improves Remodeling After Myocardial InfarctionSignificance
- (2015) Yumei Ye et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Autophagic adaptations in diabetic cardiomyopathy differ between type 1 and type 2 diabetes
- (2015) Hiromitsu Kanamori et al. Autophagy
- Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy
- (2015) Guanghong Jia et al. Nature Reviews Endocrinology
- Chronic Treatment With Ticagrelor Limits Myocardial Infarct Size
- (2014) Manjyot K. Nanhwan et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- PTEN Upregulation May Explain the Development of Insulin Resistance and Type 2 Diabetes with High Dose Statins
- (2014) Yochai Birnbaum et al. CARDIOVASCULAR DRUGS AND THERAPY
- Mammalian Target of Rapamycin Signaling in Cardiac Physiology and Disease
- (2014) Sebastiano Sciarretta et al. CIRCULATION RESEARCH
- AMPK attenuates microtubule proliferation in cardiac hypertrophy
- (2013) John T. Fassett et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Regulation of fatty acid metabolism by mTOR in adult murine hearts occurs independently of changes in PGC-1α
- (2013) Yi Zhu et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Upregulated NLRP3 Inflammasome Activation in Patients With Type 2 Diabetes
- (2012) Hye-Mi Lee et al. DIABETES
- Rapamycin-Induced Insulin Resistance Is Mediated by mTORC2 Loss and Uncoupled from Longevity
- (2012) D. W. Lamming et al. SCIENCE
- mTOR attenuates the inflammatory response in cardiomyocytes and prevents cardiac dysfunction in pathological hypertrophy
- (2010) Xiaoxiao Song et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice
- (2010) Denghong Zhang et al. JOURNAL OF CLINICAL INVESTIGATION
- Metformin Prevents Myocardial Reperfusion Injury by Activating the Adenosine Receptor
- (2009) Marta Paiva et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Anti-hypertrophic effect of NHE-1 inhibition involves GSK-3β-dependent attenuation of mitochondrial dysfunction
- (2009) Sabzali Javadov et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
- (2009) Lars Wallentin et al. NEW ENGLAND JOURNAL OF MEDICINE
- AMPK Phosphorylation of Raptor Mediates a Metabolic Checkpoint
- (2008) Dana M. Gwinn et al. MOLECULAR CELL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now